(Нет сведений об экземплярах) Шифр: ЕУ12/2017/39/2 Журнал 2017г. т.39 N 2 Sak, K. Current epidemiological knowledge about the role of flavonoids in prostate carcinogenesis / K. Sak. - P.98-105 Zalutski, I. V. Influence of exogenous lactoferrin on the oxidant/antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro / I. V. Zalutski [et. al.]. - P.106-111 Другие авторы: Lukianova N. Y., Storchai D. M., Burlaka A. P., Shvets Y. V., Borikun T. V., Todor I. M., Lukashevich V. S., Rudnichenko Y. A., Chekhun V. F. Kolesnik, D. L. Impact of lactic acidosis on the survival of lewis lung carcinoma cells / D. L. Kolesnik, O. N. Pyaskovskaya, G. I. Solyanik. - P.112-116 Tzerkovsky, D. A. Multiple-field interstitial photodynamic therapy of subcutaneously transplanted cholangiocellular carcinoma RS-1 in rats / D. A. Tzerkovsky. - P.117-120 Krasnopolsky, Y. M. Experimental study of liposomal docetaxel analysis of docetaxel incorporation and stability / Y. M. Krasnopolsky, A. S. Dudnichenko. - P.121-123 Gerina-Berzina, A. Determination of cisplatin in human blood plasma and urine using liquid chromatography-mass spectrometry for oncological patients with a variety of fatty tissue mass for prediction of toxicity / A. Gerina-Berzina [et. al.]. - P.124-130 Другие авторы: Hasnere S., Kolesovs A., Umbrashko S., Muceniece R., Nakurte I. Rosenberg, E. E. Expression of cancer-associated genes in prostate tumors / E. E. Rosenberg [et. al.]. - P.131-137 Другие авторы: Gerashchenko G. V., Hryshchenko N. V., Mevs L. V., Nekrasov K. A., Lytvynenko R. A., Vitruk Y. V., Gryzodub O. P., Stakhovsky E. A., Kashuba V. I. Vernygorodskyi, S. Lectin binding patterns in normal, dysplastic and Helicobacter pylori infected gastric mucosa / S. Vernygorodskyi, V. Shkolnikov, D. Suhan. - P.138-140 Andreieva, S. V. Comparison of chromosomal rearrangements in bone marrow cells and blast transformed B-cells in relapse of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma / S. V. Andreieva [et. al.]. - P.141-144 Другие авторы: Korets K. V., Ruzhinska O. E., Skorokhod I. M., Alkhimova O. G. Deryusheva, I. V. Genome-wide association study of loss of heterozygosity and metastasis-free survival in breast cancer patients / I. V. Deryusheva [et. al.]. - P.145-150 Другие авторы: Tsyganov M. M., Garbukov E. Y., Ibragimova M. K., Kzhyshkovska Ju. G., Slonimskaya E. M., Cherdyntseva N. V., Litviakov N. V. Lejniece, S. Generic Imatinib in the treatment of chronic myeloid leukemia: two years' experience in Latvia / S. Lejniece, I. Udre, A. Rivkina. - P.151-154 Kozlov, V. Adenocarcinoma of the lung with rare insertion mutation in EGFR exon 19 that had partial response to gefitinib: a case report / V. Kozlov [et. al.]. - P.155-156 Другие авторы: Karpov I., Kovalenko S., Shamanin V. "New trends in cancer research and innovative tumor vaccines", mini-symposium held on may 11, 2017 during the vactrain summer school in Kyiv, Ukraine / materials. - P.157-160 Dzmitruk, V. Comparison of different kind of dendrimers for the anticancer RNAi guides delivery / V. Dzmitruk [et. al.]. - P.157 Другие авторы: Ionov M., Shcharbin D., Bryszewska M. Gordiienko, I. Simultaneous CD 150 and CD 180 ligation mutually inhibit akt mapk signal transduction pathways in the chronic lymphocytic leukemia B cells / I. Gordiienko [et. al.]. - P.158 Другие авторы: Shlapatska L., Kholodniuk V., Sklyarenko L., Sidorenko S. Horak, I. Adaptor protein Ruk/CIN85 increases tumorigenicity of mammary adenocarcinoma cells via promoting EMT / I. Horak [et. al.]. - P.158 Другие авторы: Pasichnyk G., Shytikov D., Geraschenko D., Drobot L. Mankovska, O. Identification of novel molecular and genetic markers for early detection of epithelial tumors and prognosis of the course of disease / O. Mankovska, V. Kashuba. - P.158 Mezale, D. Diagnostic value of neutrophil/lymphocyte ratio in hepatocellular carcinoma and focal nodular huperplasia: a pilot study / D. Mezale [et. al.]. - P.158-159 Другие авторы: Strumfa I., Vanags A., Fridrihsone I., Viktorova P. Mushtaq, M. Interplay between mitochondrial ribosomal protein S 18-2 and retinoblastoma susceptibility (RB) protein in regulation of cell stemness and differentation / M. Mushtaq, L. Kovalevska, E. Kashuba. - P.159 Ratushna, O. Inhibition of IRE1 signaling affects the expression of genes encoding glucocorticoid receptor and some related proteins in U87 glioma cells / O. Ratushna [et. al.]. - P.159-160 Другие авторы: Minchenko D., Riabovol O., Minchenko O. Rosenberg, E. Expression of cancer-associated genes in prostate tumors / E. Rosenberg [et. al.]. - P.160 Другие авторы: Gerashchenko G., Hryshchenko N., Lytvynenko R., Vitruk Y., Gryzodub O., Stakhovsky E., Kashuba V. Ustinova, M. The role of epigenetics in the development of type 2 diabetes and effectiveness of Metformin therapy / M. Ustinova [et al.]. - P.160 Другие авторы: Kalnina I., Elbere I., Klovins J. Нет сведений об экземплярах |
Adenocarcinoma of the lung with rare insertion mutation in EGFR exon 19 that had partial response to gefitinib: a case report / V. Kozlov [et al.] // Experimental Oncology. - 2017. - Том 39, N 2. - P155-156. - 7 ref. MeSH-главная: АДЕНОКАРЦИНОМА -- ADENOCARCINOMA (генетика, диагностика, терапия) ЛЕГКИЕ -- LUNG (патология) ГЕНЫ ERBB-1 -- GENES, ERBB-1 (генетика, действие лекарственных препаратов) Кл.слова (ненормированные): gefitinib Доп.точки доступа: Kozlov, V.; Karpov, I.; Kovalenko, S.; Shamanin, V. Экз-ры: |